Becton, Dickinson and Company

BDX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $1.68B $1.71B $1.48B $1.78B $2.09B $874.0M $1.23B $311.0M
Depreciation & Amortization $2.46B $2.29B $2.29B $2.23B $2.23B $2.12B $2.25B $1.98B
Depreciation $728.0M $676.0M $696.0M $672.0M $689.0M $608.0M $633.0M $600.0M
Amortization $1.59B $1.47B $1.47B $1.43B $1.40B $1.38B $1.50B $1.26B
Stock-Based Compensation $258.0M $247.0M $259.0M $233.0M $229.0M $236.0M $261.0M $322.0M
Net Cash from Operating Activities $3.43B $3.84B $2.99B $2.47B $4.65B $3.54B $3.33B $2.87B
Investing Activities
Capital Expenditures $760.0M $725.0M $874.0M $973.0M $1.19B $769.0M $957.0M $895.0M
Business Acquisitions $0 $3.92B $0 $2.07B $508.0M $164.0M $0 $15.16B
Net Cash from Investing Activities $-818.0M $-5.51B $-716.0M — $-1.88B $-1.23B $-741.0M $-15.73B
Financing Activities
Dividends Paid $1.20B $1.10B $1.11B $1.08B $1.05B $1.03B $984.0M $927.0M
Stock Repurchases $1.00B $500.0M $0 $500.0M $1.75B $0 $0 $0
Net Cash from Financing Activities $-3.62B $2.09B $-1.96B — $-3.31B $22.0M $-3.22B $-58.0M
Net Change in Cash $-1.01B $375.0M $322.0M $-1.23B $-525.0M $2.33B $-646.0M $-13.04B
Free Cash Flow $2.67B $3.12B $2.12B $1.50B $3.45B $2.77B $2.37B $1.97B
← Newer Page 1 of 3 Older →